YangLiuMD

PubMed

• 108 citations
  Super-Resolution Imaging of Higher-Order Chromatin Structures at Different Epigenomic States in Single Mammalian Cells.
  Jianquan Xu, Hongqiang Ma, Jingyi Jin, Shikhar Uttam, Rao Fu
  Cell Reports. 2018-07-24
• 65 citations
  Super-resolution Imaging Reveals the Evolution of Higher-Order Chromatin Folding in Early Carcinogenesis
  Jianquan Xu, Hongqiang Ma, Hongbin Ma, Wei Jiang, Christopher A. Mela
  Nature Communications. 2020-04-20
• 86 citations
  Concentric organization of A- and B-type lamins predicts their distinct roles in the spatial organization and stability of the nuclear lamina.
  Bruce Nmezi, Jianquan Xu, Rao Fu, Travis J. Armiger, Guillermo Rodríguez-Bey
  Proceedings of the National Academy of Sciences of the United States of America. 2019-02-14

Abstracts/Posters

• Pdox Models Empower Preclinical Drug Evaluation and Mechanistic Studies Via Faithful Recapitulation of the Pathology, Complex Heterogeneity, Genetic-Transcriptomic Lan...
  Yang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Genetically Defined Metabolic Targets Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
  Yang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• BI-1206, a Monoclonal Antibody Against Fc_riib, Showed Superior Anti-Tumor Activity in an Ibrutinib-Venetoclax Dual Resistant PDX Model in Mantle Cell Lymphoma
  Yang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Targeting PI3K and PLK1 to Overcome Ibrutinib-Venetoclax Resistance in Mantle Cell Lymphoma
  Yang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Identify AMPK-Mediated Autophagy and Oxphos As a Novel Metabolic Vulnerability for Targeted Therapy in Mantle Cell Lymphoma
  Yang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Clinical efficacy of tumor-treating fields for newly diagnosed glioblastoma. 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
• The Development of a Precision Medicine Platform to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019